Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 10:41 am Sale | 2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | Foresite Capital Fund III L.P. | 3,428,898 5.000% | -390,828 (-10.23%) | Filing History |
| 2021-02-10 10:46 am Sale | 2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | VANGUARD GROUP INC | 3,427,011 4.970% | -264,314 (-7.16%) | Filing History |
| 2021-01-29 09:57 am Sale | 2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | BlackRock Inc. BLK | 5,386,244 7.800% | -203,607 (-3.64%) | Filing History |
| 2020-09-24 4:47 pm Purchase | 2020-09-14 | 13G | CymaBay Therapeutics, Inc. CBAY | Boxer Capital LLC | 4,000,000 5.800% | 4,000,000 (New Position) | Filing History |
| 2020-09-01 12:25 pm Purchase | 2020-08-31 | 13G | CymaBay Therapeutics, Inc. CBAY | venBio Select Advisor LLC | 10,300,000 14.950% | 4,800,000 (+87.27%) | Filing History |
| 2020-06-05 4:02 pm Purchase | 2020-05-26 | 13G | CymaBay Therapeutics, Inc. CBAY | D. E. SHAW & CO L.P. | 3,449,612 5.000% | 3,449,612 (New Position) | Filing History |
| 2020-05-13 09:00 am Sale | 2020-05-12 | 13D | CymaBay Therapeutics, Inc. CBAY | Engine Capital L.P. | 2,097,676 3.000% | -4,346,301 (-67.45%) | Filing History |